Saptak Chem & Stock Price Today (NSE: SAPK)

Saptak Chem &

20.97+0.00 (+0.00%)
Market Closed

Fundamental Score

...

Saptak Chem & Share Price — Live NSE/BSE Price, Fundamentals & Analysis

Saptak Chem & share price today is 20.97, up +0.00% on NSE/BSE as of 17 April 2026. Saptak Chem & (SAPK) is a Small-cap company in the Trading & Distributors sector with a market capitalisation of 2.25 (Cr). The 52-week high for SAPK share price is N/A and the 52-week low is N/A.

Saptak Chem & Share Price Chart — NSE/BSE Historical Performance

No data
High
20.97
Low
20.97
Volume
0
Change
+0.00%

Saptak Chem & share price chart: 0.00% return over the past month. 52-week high ₹N/A, 52-week low ₹N/A.

AI Research Briefing

Powered by Gemini · 2026-04-17

This micro-cap is a distressed asset play dependent on new investors, with a high risk of collapse.

Research Confidence
6.0/10Moderate
DEBT TRAP TURNAROUNDPrice has seen a significant increase in the last 1M (47.68%), 3M (366.0%), and 6M (446.09%).P/E is non-existent. Industry P/E is 35.45x.

WHAT'S HAPPENING NOW (last 2-4 weeks)

Saptak Chem has seen significant equity restructuring. Ankush Agarwal HUF and Jayshree Jain acquired stakes of 16.27% and 9.86% respectively via preferential allotment on April 6, 2026. These deals substantially increased the company's equity base. Separately, the company converted 2,000,000 warrants into equity shares on the same day, raising

CORE STORY (THE REAL GAME)

This is a capital restructuring play, not an operating turnaround story. Market is betting on new investors to revive a distressed micro-cap, not on inherent business strength.

Why Now
  • Capital infusion of ₹1.58 crore via warrant conversion
  • Acquisition of 16.27% stake by Ankush Agarwal HUF
  • Acquisition of 9.86% stake by Jayshree Jain
Potential Catalysts
  • Successful operational turnaround
  • Further equity infusions
  • Significant order wins
Key Risks
  • Micro-cap: Illiquidity risk is very high.
  • History of operational difficulties and negative book value
  • Low and decreasing promoter holding at 12.58%
Institutional Activity

Promoter holding decreased by 3.73%, DII decreased by 3.0%.

Macro Context

India's distribution sector is evolving, demanding operational efficiency.

Cash Flow Quality

Negative free cash flow of ₹-0.69 Cr over the last 5 years.

3–6 Month Outlook

The next 3-6 months will determine if the capital infusion can translate into operational improvements. Without it, the stock is likely to crash.

Primary Thesis Risk

Failure to achieve operational turnaround will lead to complete value destruction.

For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.

Returns & Performance

Return on Equity (ROE)

N/A

Profit generated per ₹1 of shareholder equity

Poor

Return on Capital (ROCE)

-66.67%

Returns generated on total capital deployed

Oper. Profit Margin (5Y Avg)

N/A

Average operating profit margin over 5 years

Dividend Yield

0.00%

Annual dividend as % of current share price

Saptak Chem & Valuation Check

Price to Earnings (P/E)

N/A

Share price ÷ earnings per share. Lower = cheaper

Poor

Industry Avg P/E

35.45x

Average P/E of all peers in this sector

Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Shareholding Pattern

Good

Promoter Holding

12.58%

% shares held by company founders/management

Poor

FII Holding

0.00%

% shares held by foreign institutional investors

Poor

DII Holding

0.00%

% held by domestic mutual funds, LIC, banks

Excellent

Promoter Pledged %

0.00%

% of promoter shares pledged as collateral — lower is safer

Growth Engine

Profit Growth (Quarterly YoY)

N/A

Net profit growth vs same quarter last year

Revenue Growth (Quarterly YoY)

N/A

Revenue growth vs same quarter last year

Revenue Growth (5-Year CAGR)

N/A

Compounded annual revenue growth over 5 years

EPS Growth (5-Year CAGR)

N/A

Earnings per share growth over 5 years

Net Profit Growth (5-Year CAGR)

N/A

Compounded annual net profit growth over 5 years

Balance Sheet Health

Debt to Equity Ratio

N/A

Total debt ÷ equity. Below 0.5 = financially healthy

Interest Coverage Ratio

N/A

EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably

Free Cash Flow (5-Year Total)

-0.69 (Cr)

Cash left after capex over 5 years. Positive = self-funded growth

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Saptak Chem & Fundamental Analysis & Valuation Benchmarking

Educational evaluation of SAPK across key market metrics for learning purposes.

Positive Indicators

1 factors identified

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

4 factors identified

Suboptimal ROCE (-66.67%)

Observation: Returns on capital employed are below expectations.

Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.

Negative Free Cash Flow (₹-0.69 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

Low Promoter Commitment (12.58%)

Observation: Reduced promoter stake may indicate limited confidence.

Analysis: Low promoter holding may raise questions about management commitment.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Saptak Chem & vs Trading & Distributors Peers

Peer Comparison - Trading & Distributors

Compare Saptak Chem & with 10 other companies in the same sector

11 companies
Company Info
Fundamental
Valuation
Profitability
Financial Health
Growth
Dividend
Company
Company name
Score
Bull Run comprehensive fundamental score based on 20+ metrics
Price
Current trading price of the stock
Market Cap
Total value of all shares in the market
P/E
Price per share divided by earnings per share
ROE
Net income divided by shareholder equity
ROCE
Earnings before interest and tax divided by capital employed
Debt/Eq
Total debt divided by total equity
Profit 5Y
Average annual profit growth over 5 years
Sales 5Y
Average annual sales growth over 5 years
Dividend
Annual dividend per share divided by price per share
0/100
21
₹2.25
-66.67%
Poor
0.00%
Redington Ltd...
REDINGTON532805
58.5/100
223
₹22049.92
16.1
Average
14.39%
Average
18.90%
Good
0.3
Excellent
17.72%
Excellent
14.06%
Good
2.41%
MMTC Ltd...
MMTC513377
32.1/100
66
₹8949.04
127.3
Average
5.87%
Poor
7.70%
Poor
0.0
Excellent
19.08%
Excellent
-86.52%
Poor
0.00%
MSTC Ltd...
MSTCLTD542597
63.7/100
439
₹3458.41
15.7
Average
28.37%
Excellent
29.26%
Excellent
0.2
Excellent
15.18%
Excellent
-24.06%
Poor
8.24%
24.7/100
405
₹3333.57
49.5
Average
26.05%
Excellent
27.44%
Excellent
0.2
Excellent
0.00%
11.1/100
154
₹2132.64
35.5
Average
17.05%
Good
15.42%
Good
0.2
Excellent
0.06%
34.8/100
379
₹1813.06
38.4
Average
9.28%
Poor
11.83%
Average
0.1
Excellent
0.00%
66.6/100
637
₹1297.46
519.0
Average
87.02%
Excellent
82.72%
Excellent
0.0
Excellent
158.76%
Excellent
66.77%
Excellent
0.00%
41.9/100
19
₹1111.34
402.7
Average
1.24%
Poor
2.46%
Poor
0.1
Excellent
61.76%
Excellent
35.83%
Excellent
0.00%
32.3/100
30300
₹1021.99
11.7
Average
9.31%
Poor
9.39%
Poor
0.0
Excellent
10.82%
Good
4.86%
Average
1.50%
62.3/100
46
₹811.32
6.4
Average
12.62%
Average
16.29%
Good
0.0
Excellent
28.35%
Excellent
61.75%
Excellent
0.00%

Saptak Chem & Quarterly Performance

Latest quarterly metrics for SAPK — revenue growth and profit growth vs same quarter last year

Revenue Growth (YoY)

N/A

Latest quarter vs same quarter previous year

Net Profit Growth (YoY)

N/A

Latest quarter net profit vs same quarter previous year

5-Year Revenue CAGR

N/A

Compounded annual revenue growth over 5 years

5-Year Profit CAGR

N/A

Compounded annual net profit growth over 5 years

Saptak Chem & Financial Statements

Annual income statement, balance sheet and cash flow for Saptak Chem & (SAPK) — sourced from NSE/BSE filings.

Loading Financial Statements...

Fetching financial data for Saptak Chem &

About SAPK (Saptak Chem &)

Saptak Chem & (SAPK) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Trading & Distributors sector with a curre...nt market capitalisation of ₹2.25 (Cr). Investors tracking SAPK share price can monitor key metrics including P/E ratio, promoter holding of 12.58%, and quarterly earnings growth.

Company Details

Symbol:SAPK
Industry:Trading & Distributors
Sector:Trading & Distributors
Website:N/A

SAPK Share Price: Frequently Asked Questions

What is the current share price of Saptak Chem &?

Saptak Chem & (SAPK) trades at ₹20.97 on NSE and BSE. Market cap ₹2.25 (Cr). Educational data only.

What is the P/E ratio of Saptak Chem &?

Saptak Chem & has a P/E of N/Ax vs industry average 35.45x.

What is the Bull Run score for Saptak Chem &?

Saptak Chem & has a Bull Run score of 0/100 based on 25+ financial parameters.

Does Saptak Chem & pay dividends?

Saptak Chem & has a dividend yield of 0.00%. Past dividends don't guarantee future payments.

What is the ROE of Saptak Chem &?

Saptak Chem & has ROE of N/A. Higher ROE indicates better use of shareholder equity.

What is the debt-to-equity ratio of Saptak Chem &?

Saptak Chem & has debt-to-equity of N/A.

Is Saptak Chem & a good investment?

Bull Run gives Saptak Chem & a score of 0/100. This is not investment advice — consult a SEBI-registered advisor.